Vanda Pharmaceuticals Inc

Research Vanda Pharmaceuticals Inc (VNDA) on Bullrun: market cap USD 369.23M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVNDA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 369.23M
• Financial periodFY2025
• RevenueUSD 216.11M
• Revenue growth8.7%
• Net income-USD 220.50M
• Free cash flow-USD 110.44M

Valuation Snapshot

latest market cap is USD 369.23M.

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis;

Frequently asked questions

What is Vanda Pharmaceuticals Inc's market cap?

Vanda Pharmaceuticals Inc's market capitalization is USD 369.23M.

What does Vanda Pharmaceuticals Inc do?

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.